Insider Trading History of Tyle Praveen

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Tyle Praveen since 2007. This trader's CIK number is 1296936. At the time of last reporting, Tyle Praveen was the Director of Kiora Pharmaceuticals Inc. (stock ticker symbol KPRX). Also see all insider trading activities at Kiora Pharmaceuticals Inc.

Note that in the past TYLE PRAVEEN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Tyle Praveen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 LXRX 0 $0 0 $0 68,007 $0
2020 LXRX 0 $0 0 $0 39,316 $0
2019 LXRX 0 $0 0 $0 12,717 $0
2018 LXRX 0 $0 0 $0 2,990 $0

Yearly summary of insider trading at Kiora Pharmaceuticals Inc (KPRX) by Tyle Praveen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 KPRX 5,000 $19,800 0 $0 0 $0

Yearly summary of insider trading at Lomb Inc (BOL) by Tyle Praveen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 BOL 0 $0 0 $0 18,025 $0


Insider trading activities at 3 companies by Tyle Praveen:

1. Lexicon Pharmaceuticals, Inc. (LXRX)

2. Kiora Pharmaceuticals Inc (KPRX)

3. Lomb Inc (BOL)

Table 1. Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Tyle Praveen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-28 LXRX Option Ex 68,007 .00 0
2020-02-28 LXRX Option Ex 39,316 .00 0
2019-02-28 LXRX Option Ex 12,717 .00 0
2018-02-28 LXRX Option Ex 2,990 .00 0

Table 2. Insider trading of Kiora Pharmaceuticals Inc (KPRX) by Tyle Praveen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-19 KPRX Buy 5,000 3.96 19,800

Table 3. Insider trading of Lomb Inc (BOL) by Tyle Praveen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-10-26 BOL Option Ex 18,025 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tyle Praveen (Director of Kiora Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.